Literature DB >> 23886567

Is there clinical value in measuring suPAR levels in FSGS?

Sanja Sever, Howard Trachtman, Changli Wei, Jochen Reiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23886567      PMCID： PMC3731899          DOI： 10.2215/CJN.06170613

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  13 in total

Review 1.  Focal segmental glomerulosclerosis.

Authors:  Vivette D D'Agati; Frederick J Kaskel; Ronald J Falk
Journal:  N Engl J Med       Date:  2011-12-22       Impact factor: 91.245

2.  Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.

Authors:  Margret E Bock; Heather E Price; Lorenzo Gallon; Craig B Langman
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 8.237

3.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Authors:  Changli Wei; Shafic El Hindi; Jing Li; Alessia Fornoni; Nelson Goes; Junichiro Sageshima; Dony Maiguel; S Ananth Karumanchi; Hui-Kim Yap; Moin Saleem; Qingyin Zhang; Boris Nikolic; Abanti Chaudhuri; Pirouz Daftarian; Eduardo Salido; Armando Torres; Moro Salifu; Minnie M Sarwal; Franz Schaefer; Christian Morath; Vedat Schwenger; Martin Zeier; Vineet Gupta; David Roth; Maria Pia Rastaldi; George Burke; Phillip Ruiz; Jochen Reiser
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

Review 4.  Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  Ellen T McCarthy; Mukut Sharma; Virginia J Savin
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-21       Impact factor: 8.237

5.  "The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma.

Authors:  M Sharma; R Sharma; E T McCarthy; V J Savin
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

6.  Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis.

Authors:  Jing Huang; Gang Liu; Yi-Miao Zhang; Zhao Cui; Fang Wang; Xiao-Jing Liu; Rong Chu; Ying Chen; Ming-Hui Zhao
Journal:  Kidney Int       Date:  2013-02-27       Impact factor: 10.612

7.  Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.

Authors:  Carlos R Franco Palacios; John C Lieske; Hani M Wadei; Andrew D Rule; Fernando C Fervenza; Nikolay Voskoboev; Vesna D Garovic; Ladan Zand; Mark D Stegall; Fernando G Cosio; Hatem Amer
Journal:  Transplantation       Date:  2013-08-27       Impact factor: 4.939

8.  Circulating suPAR in two cohorts of primary FSGS.

Authors:  Changli Wei; Howard Trachtman; Jing Li; Chuanhui Dong; Aaron L Friedman; Jennifer J Gassman; June L McMahan; Milena Radeva; Karsten M Heil; Agnes Trautmann; Ali Anarat; Sevinc Emre; Gian M Ghiggeri; Fatih Ozaltin; Dieter Haffner; Debbie S Gipson; Frederick Kaskel; Dagmar-Christiane Fischer; Franz Schaefer; Jochen Reiser
Journal:  J Am Soc Nephrol       Date:  2012-11-08       Impact factor: 10.121

9.  Modification of kidney barrier function by the urokinase receptor.

Authors:  Changli Wei; Clemens C Möller; Mehmet M Altintas; Jing Li; Karin Schwarz; Serena Zacchigna; Liang Xie; Anna Henger; Holger Schmid; Maria P Rastaldi; Peter Cowan; Matthias Kretzler; Roberto Parrilla; Moïse Bendayan; Vineet Gupta; Boris Nikolic; Raghu Kalluri; Peter Carmeliet; Peter Mundel; Jochen Reiser
Journal:  Nat Med       Date:  2007-12-16       Impact factor: 53.440

Review 10.  suPAR: the molecular crystal ball.

Authors:  Maria Thunø; Betina Macho; Jesper Eugen-Olsen
Journal:  Dis Markers       Date:  2009       Impact factor: 3.434
View more
  10 in total

1.  Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome.

Authors:  Jutta Gellermann; Franz Schaefer; Uwe Querfeld
Journal:  Pediatr Nephrol       Date:  2014-08-17       Impact factor: 3.714

2.  Serum suPAR levels help differentiate steroid resistance from steroid-sensitive nephrotic syndrome in children.

Authors:  Zhaoyang Peng; Jianhua Mao; Xuejun Chen; Fengqing Cai; Weizhong Gu; Haidong Fu; Huijun Shen; Jingjing Wang; Xia Jin; Xiujuan Zhu; Aimin Liu; Qiang Shu; Lizhong Du
Journal:  Pediatr Nephrol       Date:  2014-07-18       Impact factor: 3.714

3.  Soluble urokinase-type plasminogen activator receptor in FSGS: stirred but not shaken.

Authors:  Jochen Reiser; Harold Chapman
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121

4.  Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS.

Authors:  Furong Li; Chunxia Zheng; Yongzhong Zhong; Caihong Zeng; Feng Xu; Ru Yin; Qi Jiang; Minlin Zhou; Zhihong Liu
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-15       Impact factor: 8.237

Review 5.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

Review 6.  Permeability factors in focal and segmental glomerulosclerosis.

Authors:  Jochen Reiser; Cynthia C Nast; Nada Alachkar
Journal:  Adv Chronic Kidney Dis       Date:  2014-09       Impact factor: 3.620

7.  Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis.

Authors:  Yutaka Harita; Kiyonobu Ishizuka; Atsushi Tanego; Noriko Sugawara; Hiroko Chikamoto; Yuko Akioka; Haruko Tsurumi; Kenichiro Miura; Yoshimitsu Gotoh; Makoto Tsujita; Takayuki Yamamoto; Keiji Horike; Asami Takeda; Akira Oka; Takashi Igarashi; Motoshi Hattori
Journal:  Pediatr Nephrol       Date:  2014-04-06       Impact factor: 3.714

8.  The novel diagnostic biomarkers for focal segmental glomerulosclerosis.

Authors:  Mohsen Nafar; Shiva Kalantari; Shiva Samavat; Mostafa Rezaei-Tavirani; Dorothea Rutishuser; Roman A Zubarev
Journal:  Int J Nephrol       Date:  2014-03-26

Review 9.  Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis.

Authors:  Crislaine Aparecida da Silva; Mariana Molinar Mauad Cintra; Eliângela de Castro Côbo; Marcos Vinícius da Silva; Fabiano Bichuette Custódio; Rosana Rosa Miranda Corrêa; Lúcio Roberto Castellano; Marlene Antônia dos Reis; Juliana Reis Machado
Journal:  Dis Markers       Date:  2014-02-25       Impact factor: 3.434

Review 10.  Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.

Authors:  Andreas Kronbichler; Moin A Saleem; Björn Meijers; Jae Il Shin
Journal:  J Immunol Res       Date:  2016-07-18       Impact factor: 4.818
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.